Intravitreal triamcinolone for nonarteritic anterior ischemic optic neuropathy.
Hayreh
Sohan Singh
SS
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D007267:Injections; D015588:Observer Variation; D009900:Optic Nerve / Q000098:blood supply / Q000187:drug effects / Q000503:physiopathology; D018917:Optic Neuropathy, Ischemic / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D010211:Papilledema / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D012107:Research Design; D012161:Retinal Artery / Q000187:drug effects / Q000503:physiopathology; D018401:Sample Size; D016896:Treatment Outcome; D014221:Triamcinolone / Q000008:administration & dosage*; D015354:Vision, Low / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D014822:Vitreous Body / Q000502:physiology
D000893:Anti-Inflammatory Agents; D014221:Triamcinolone